Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03637764
Title Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sanofi
Indications

head and neck squamous cell carcinoma

hepatocellular carcinoma

glioblastoma

ovary epithelial cancer

Therapies

Atezolizumab + Isatuximab

Isatuximab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | BEL


No variant requirements are available.